| Business Name: |
Dispute Doctors |
| Contact Person: |
Robert Brennan |
| Address: |
101 Eisenhower Parkway # 101, Roseland, New Jersey 07068 |
| Phone Number: |
(973) 464-7274 |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Founding Year: |
2010 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
621111 |
| Share This Business: |
|
| Related Businesses: |
Mamoun Plastic Surgery - Roseland, NJ 07068
Mintz Shari N MD - Roseland, NJ 07068
Makhlouf Jean MD - Roseland, NJ 07068
Elfenbein Emanuel MD - Roseland, NJ 07068
Klein Richard L MD - Roseland, NJ 07068
Weinberger Daniela MD - Roseland, NJ 07068
Rutgers The State University Of New Jersey - Roseland, NJ 07068
Fischer Jr Edward DC - Roseland, NJ 07068
Di Trolio Joseph V - Roseland, NJ 07068
Caputo Anthony R MD - Roseland, NJ 07068
Richard Schenk Md - Roseland, NJ 07068
Kopacz Kenneth J MD - Roseland, NJ 07068
Turbin Roger E MD - Roseland, NJ 07068
Gorman Eugene S MD - Roseland, NJ 07068
Ioffe Inna S MD - Roseland, NJ 07068
Anello Tiziana MD - Roseland, NJ 07068
Smith Stephen M MD - Roseland, NJ 07068
Assoc of Infectious Disease - Roseland, NJ 07068
Essex Endocrine Assoc - Roseland, NJ 07068
Scannapiego Saveren - Roseland, NJ 07068
|
The company Dispute Doctors provides B2C services in the form of Doctors from its single location in New Jersey.
1 to 4 employees work for Dispute Doctors, and the business now earns $100.000 to $499.999 per annum.
Dispute Doctors was launched in 2010 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 .
To contact Dispute Doctors, please call Robert Brennan with the phone number (973) 464-7274 or visit its single location at 101 Eisenhower Parkway # 101 in Roseland, New Jersey 07068.
The location of the single location can also be found using the coordinates 40.827861,-74.319386.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.